AlzChem AG postpones planned IPO

08-Feb-2017 - Germany

AlzChem AG is postponing its planned IPO. The first day of trading of the shares of AlzChem AG in the Regulated Market (Prime Standard) of the Frankfurt Stock Exchange was initially planned for February 10, 2017.

Although index levels are relatively high at the moment, the market environment currently dominated by political issues caused persistent uncertainty when it comes to making new investments. Despite significant institutional investor interest in Europe and the USA, a placement within the aspired price range was therefore ultimately not possible.

Ulli Seibel, CEO of AlzChem AG, comments: “We want to thank the investors who have subscribed as well as those who have analyzed the company. Special thanks also go to our employees, consultants and banking teams who worked with great commitment on the IPO. Even without an IPO in the near future, we will continue on our growth path and invest in the further development of our Specialty Chemicals business segment. We will now make use of alternative financing options for this purpose.”

AlzChem will re-evaluate the possibility of an IPO at some stage in the future.

https://www.chemeurope.com/en/news/161782/alzchem-ag-postpones-planned-ipo.html